Search Results - "JOCHUM, Simon"
-
1
Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2
Published in Journal of clinical microbiology (22-09-2020)“…The Elecsys Anti-SARS-CoV-2 immunoassay (Roche Diagnostics) was developed to provide accurate, reliable detection of antibodies to severe acute respiratory…”
Get full text
Journal Article -
2
The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination
Published in PLoS pathogens (01-05-2012)“…Lifelong persistence of Epstein-Barr virus (EBV) in infected hosts is mainly owed to the virus' pronounced abilities to evade immune responses of its human…”
Get full text
Journal Article -
3
Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial
Published in Frontiers in immunology (19-01-2022)“…The ability to quantify an immune response after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential. This study…”
Get full text
Journal Article -
4
Design and performance characteristics of the Elecsys anti-SARS-CoV-2 S assay
Published in Frontiers in immunology (02-12-2022)“…Automated, high throughput assays are required to quantify the immune response after infection with or vaccination against severe acute respiratory syndrome…”
Get full text
Journal Article -
5
RNAs in Epstein–Barr virions control early steps of infection
Published in Proceedings of the National Academy of Sciences - PNAS (22-05-2012)“…Herpesviruses are dsDNA viruses, but their virions may additionally contain RNAs that can be transduced to recipient cells. The biological functions of herpes…”
Get full text
Journal Article -
6
EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL
Published in PloS one (10-10-2011)“…gp350, the major envelope protein of Epstein-Barr-Virus, confers B-cell tropism to the virus by interacting with the B lineage marker CD21. Here we utilize…”
Get full text
Journal Article -
7
A Virus-Like Particle-Based Epstein-Barr Virus Vaccine
Published in Journal of Virology (01-12-2011)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
8
In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients
Published in Infectious diseases and therapy (01-09-2021)“…Background Quantitative serological assays detecting response to SARS-CoV-2 are needed to quantify immunity. This study analyzed the performance and…”
Get full text
Journal Article -
9
Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection
Published in International journal of molecular sciences (01-11-2023)“…COVID-19 has highlighted challenges in the measurement quality and comparability of serological binding and neutralization assays. Due to many different assay…”
Get full text
Journal Article -
10
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
Published in Gut (01-10-2021)“…Delayed second dose SARS-CoV-2 vaccination trades maximal effectiveness for a lower level of immunity across more of the population. We investigated whether…”
Get more information
Journal Article -
11
Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC
Published in Cancer Immunology, Immunotherapy (01-05-2011)“…In order to grow within an immunocompetent host, tumour cells have evolved various strategies to cope with the host’s immune system. These strategies include…”
Get full text
Journal Article -
12
Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel
Published in Diagnostic microbiology and infectious disease (01-11-2021)“…•We evaluated the analytical performance of the Elecsys® EBV immunoassay panel.•The Elecsys EBV panel comprises tests for EBV IgM, EBV VCA IgG, and EBV EBNA…”
Get full text
Journal Article -
13
Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following mRNA-1273 (Spikevax) Vaccination Against COVID-19
Published in Infectious diseases and therapy (01-01-2023)“…Introduction There is a need for automated, high-throughput assays to quantify immune response after SARS-CoV-2 vaccination. This study assessed the combined…”
Get full text
Journal Article -
14
RNAs in Epstein-Barr virions control early steps of infection
Published in Proceedings of the National Academy of Sciences - PNAS (22-05-2012)Get full text
Journal Article -
15
In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients
Published in Infectious diseases and therapy (16-06-2021)“…Quantitative serological assays detecting response to SARS-CoV-2 are needed to quantify immunity. This study analyzed the performance and correlation of two…”
Get full text
Journal Article